- Home
- RY vs BSX Comparison
RY vs BSX Comparison
Compare RY & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RY
- BSX
- Stock Information
- Founded
- RY 1864
- BSX 1979
- Country
- RY Canada
- BSX United States
- Employees
- RY N/A
- BSX N/A
- Industry
- RY
- BSX Medical/Dental Instruments
- Sector
- RY
- BSX Health Care
- Exchange
- RY Nasdaq
- BSX Nasdaq
- Market Cap
- RY 186.5B
- BSX 157.6B
- IPO Year
- RY N/A
- BSX 1992
- Fundamental
- Price
- RY $145.99
- BSX $99.25
- Analyst Decision
- RY Strong Buy
- BSX Strong Buy
- Analyst Count
- RY 2
- BSX 22
- Target Price
- RY $177.50
- BSX $121.09
- AVG Volume (30 Days)
- RY 939.5K
- BSX 10.2M
- Earning Date
- RY 12-03-2025
- BSX 10-22-2025
- Dividend Yield
- RY 2.92%
- BSX N/A
- EPS Growth
- RY 18.99
- BSX 36.90
- EPS
- RY 9.55
- BSX 1.68
- Revenue
- RY $43,552,874,021.00
- BSX $18,494,000,000.00
- Revenue This Year
- RY $25.11
- BSX $19.85
- Revenue Next Year
- RY $3.05
- BSX $11.07
- P/E Ratio
- RY $15.11
- BSX $59.07
- Revenue Growth
- RY 16.26
- BSX 21.44
- 52 Week Low
- RY $106.10
- BSX $80.64
- 52 Week High
- RY $149.26
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- RY 55.28
- BSX 53.44
- Support Level
- RY $143.13
- BSX $94.53
- Resistance Level
- RY $147.30
- BSX $99.61
- Average True Range (ATR)
- RY 1.58
- BSX 2.44
- MACD
- RY -0.41
- BSX 0.51
- Stochastic Oscillator
- RY 58.73
- BSX 95.96
About RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.2 trillion in assets. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.